|
TMEM66 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.219900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.761500E-02 |
| Normal-vs-Stage2 |
1.642370E-01 |
| Normal-vs-Stage3 |
1.381010E-04 |
| Normal-vs-Stage4 |
9.400500E-03 |
| Stage1-vs-Stage2 |
6.459600E-01 |
| Stage1-vs-Stage3 |
1.543920E-02 |
| Stage1-vs-Stage4 |
1.143970E-01 |
| Stage2-vs-Stage3 |
2.105400E-01 |
| Stage2-vs-Stage4 |
3.933200E-01 |
| Stage3-vs-Stage4 |
8.359000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.784700E-03 |
| Normal-vs-AfricanAmerican |
6.946600E-01 |
| Normal-vs-Asian |
3.948400E-02 |
| Caucasian-vs-AfricanAmerican |
3.420600E-01 |
| Caucasian-vs-Asian |
9.393800E-01 |
| AfricanAmerican-vs-Asian |
3.452600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.299700E-03 |
| Normal-vs-Female |
1.717820E-02 |
| Male-vs-Female |
2.620800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.592600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.648200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.830770E-04 |
| Normal-vs-Age(81-100Yrs) |
4.392400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.910200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.482400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.870800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.215800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.438400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.417200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.12070000002351E-06 |
| Classical-VS-Follicular |
3.424400E-01 |
| Classical-VS-Other |
8.981700E-02 |
| Classical-VS-Normal |
1.306420E-01 |
| Tall-VS-Follicular |
3.156700E-03 |
| Tall-VS-Other |
9.430400E-01 |
| Tall-VS-Normal |
2.57429999539482E-08 |
| Follicular-VS-Other |
2.899200E-01 |
| Follicular-VS-Normal |
6.415500E-02 |
| Other-VS-Normal |
8.362100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.635900E-02 |
| Normal-vs-N1 |
1.14679999996259E-06 |
| N0-vs-N1 |
6.808000E-04 |
|
|
